Osteoradionecrosis of the Jaw (ORN)
Oral Medicine · Radiation-Induced Osteonecrosis
TL;DR
Osteoradionecrosis of the jaw (ORN) is necrosis of the jawbone following radiation therapy to the head and neck. It is defined as exposed bone in the field of radiation that fails to heal over 8 weeks, in the absence of recurrent or metastatic tumour. The mandible is affected far more commonly than the maxilla due to its denser cortical bone and single-vessel blood supply.
- Definition: Exposed, necrotic bone in the jaw persisting for >8 weeks in a previously irradiated field, with no evidence of tumour recurrence.
- Most important risk factor: Total radiation dose. Risk increases significantly with doses >60 Gray (Gy). Extractions after radiation are a major precipitating factor.
- Mandible > maxilla: The mandible is affected 10× more frequently than the maxilla. Reason: denser cortical bone, single inferior alveolar artery blood supply (poorly collateral), and more teeth (more potential extraction sites).
- Prevention — pre-radiation dental clearance: All teeth of questionable prognosis must be extracted BEFORE radiation therapy, with minimum 2 weeks (ideally 3 weeks) of healing before radiation begins. Extractions after radiation carry significantly higher ORN risk.
- Hyperbaric oxygen (HBO) therapy: Adjunct treatment — 20 dives (sessions) pre-operatively and 10 dives post-operatively (Marx protocol) for surgical ORN cases. HBO promotes angiogenesis and wound healing in hypoxic, hypovascular, hypocellular irradiated tissue.
Key Facts
What Is It?
Osteoradionecrosis (ORN) of the jaw is a severe, debilitating complication of radiation therapy to the head and neck. It is defined as non-healing, exposed necrotic bone within the field of radiation that persists for more than 8 weeks, in the absence of local tumour recurrence or primary bone disease. ORN most commonly affects patients who have received radiation treatment for oral, oropharyngeal, nasopharyngeal, or salivary gland cancers.
ORN is distinct from medication-related osteonecrosis of the jaw (MRONJ), which is caused by antiresorptive drugs (bisphosphonates, denosumab). Although both conditions present with exposed jaw bone, their aetiology, pathophysiology, risk factors, and some management approaches differ significantly.
Why It Matters
ORN is tested on the INBDE for its definition (exposed bone >8 weeks post-radiation with no tumour), the critical site difference (mandible > maxilla), the dose threshold (>60 Gy), pre-radiation dental clearance timing (minimum 2 weeks before RT), the Marx HBO protocol, and the ability to distinguish ORN from MRONJ. These topics recur in clinical scenarios involving patients with a head and neck cancer history.
Pathophysiology
The pathophysiology of ORN involves three interconnected processes resulting from ionising radiation damage to bone and surrounding soft tissue:
- Hypoxia: Radiation damages the vasculature supplying bone — endothelial cell death, thrombosis, and obliterative endarteritis reduce blood flow to the irradiated bone, creating chronically hypoxic tissue.
- Hypovascularity: The damage to blood vessels is progressive and permanent — the bone’s ability to mount a healing response is permanently impaired. New vessel formation (angiogenesis) is inhibited in irradiated tissue.
- Hypocellularity: Radiation depletes the osteoblast and fibroblast precursor populations. Osteoblasts cannot regenerate sufficiently to replace bone lost to osteoclast remodelling or trauma. Fibroblasts cannot synthesise collagen and matrix for wound repair.
This triad — hypoxia, hypovascular, hypocellular (Marx’s “3H” hypothesis, 1983) — results in bone that cannot heal when subjected to trauma (e.g., extraction), infection, or mucosal injury. Modern research has also highlighted the role of dysregulated bone remodelling, bacterial biofilm, and impaired immune response in ORN pathogenesis.
Risk Factors
- Total radiation dose >60 Gy — the most important modifiable risk factor. Risk is much lower below 50 Gy.
- Mandibular location of teeth or tumour — bone density and limited blood supply make the mandible disproportionately vulnerable.
- Post-radiation dental extractions — the most common precipitating event. Trauma to hypovascular irradiated bone disrupts the periosteum and cannot heal normally.
- Poor oral hygiene / periodontal disease — active infection and inflammation worsen the tissue environment and increase ORN risk.
- Smoking and alcohol — impair wound healing independently and are often present in head and neck cancer patients.
- Radiation field encompassing the mandible — tumours of the floor of mouth, tongue, tonsillar fossa, and retromolar region irradiate the mandible directly.
- Time from RT — ORN can develop weeks to decades after radiation. The cumulative lifetime risk increases with time post-RT.
- Chemotherapy concurrent with radiation (chemoradiotherapy) — intensifies tissue damage and reduces healing capacity.
- Implants in previously irradiated bone — higher failure rates; implant placement in irradiated bone is possible with HBO support but carries significantly elevated risk compared to non-irradiated sites.
Clinical Features and Diagnosis
ORN presents with a characteristic constellation of signs and symptoms within the field of previous head and neck radiation:
- Exposed necrotic bone: The cardinal sign — bare, non-healing bone visible in the oral cavity at a site within the radiation field. The exposed bone is grey-yellow to black, and does not bleed when probed. Adjacent mucosa may be erythematous, swollen, or ulcerated.
- Pain: Ranging from dull aching to severe, unremitting pain. Pain is more prominent in advanced ORN and with secondary infection.
- Trismus: Radiation fibrosis of masticatory muscles progressively limits mouth opening over time. Trismus complicates ORN examination and treatment.
- Paraesthesia or anaesthesia of the inferior alveolar nerve: When the mandibular canal is involved, patients may experience lip numbness.
- Orocutaneous fistula: In advanced ORN, necrosis breaks through the skin, creating an opening between the oral cavity and the skin surface.
- Pathological fracture: Severe ORN can weaken the mandible to the point of spontaneous fracture.
- Secondary infection: Exposed necrotic bone is colonised by oral microorganisms; suppuration, foul odour, and cellulitis may occur.
Diagnosis is primarily clinical — exposed non-healing bone >8 weeks post-radiation, with exclusion of tumour recurrence. Imaging (panoramic radiograph, CT, MRI) documents the extent of bony involvement. Biopsy of the necrotic bone or adjacent tissue is important to exclude tumour recurrence at the ORN site, which can mimic ORN clinically.
Staging
Several staging systems exist for ORN. The Marx (1983) staging system and the CTCAE (Common Terminology Criteria for Adverse Events) grading are most commonly referenced in the literature and on licensing examinations:
| Stage | Description | Clinical Features | Management Approach |
|---|---|---|---|
| Stage I | Superficial ORN — responds to HBO | Exposed bone confined to alveolar process; no cortical involvement; no orocutaneous fistula; no pathological fracture | Conservative: HBO (20 pre-op + 10 post-op), gentle debridement, antibiotics, oral rinses |
| Stage II | ORN not responding to HBO | Exposed bone that does not resolve after a course of HBO; deeper involvement but no fistula or fracture | Surgical resection + HBO adjunct (20 pre-op + 10 post-op); debridement, sequestrectomy |
| Stage III | Advanced ORN — full-thickness involvement | Full-thickness bone involvement; pathological fracture OR orocutaneous fistula OR extension below the inferior border of the mandible | Aggressive resection to viable bleeding bone margins; microvascular free flap reconstruction; HBO perioperatively |
Prevention — Pre-Radiation Dental Clearance
Prevention of ORN is far more effective than treatment. The cornerstone of prevention is thorough dental evaluation and treatment before radiation therapy begins. Every patient scheduled for head and neck radiation involving the oral cavity or jaws should undergo a comprehensive dental assessment, typically coordinated between the radiation oncologist, oral surgeon, and dentist before the start of radiation.
Pre-Radiation Dental Protocol
- Comprehensive dental examination: Full periapical and panoramic radiographic survey; assessment of all teeth in the planned radiation field for their prognosis.
- Extraction of all teeth of doubtful prognosis within the radiation field before radiation begins. This includes teeth with deep caries, advanced periodontal disease, periapical pathology, broken roots, and partially erupted third molars.
- Timing: Extractions should be completed with a minimum healing period of 2 weeks (ideally 3 weeks) before radiation begins. This allows primary socket healing before the bone is irradiated. Inadequate healing time at the start of RT dramatically increases the risk of ORN developing at the extraction site.
- Teeth with good prognosis that are restorable can be retained — these should receive definitive restorations before radiation, along with meticulous oral hygiene instructions and fluoride therapy.
- Fluoride trays: Custom fluoride trays (daily application of high-concentration fluoride gel, 1.1% NaF) are fabricated to prevent post-radiation dental caries, which develops due to xerostomia from salivary gland damage by radiation.
- Ongoing monitoring: After completion of radiation, patients require lifelong dental surveillance with a conservative approach — avoiding extractions wherever possible, especially in the mandible.
Management
Conservative Management (Stage I)
- Hyperbaric oxygen therapy (HBO) — Marx protocol: 20 pre-operative dives at 2.4 atmospheres absolute (ATA), 100% oxygen, 90 minutes per session; 10 post-operative dives after surgical debridement. HBO promotes angiogenesis (new blood vessel formation) and recruits fibroblasts and osteoblasts to the hypoxic tissue.
- Gentle debridement of sequestra (pieces of dead bone) without major resection
- Antimicrobial oral rinses (chlorhexidine 0.12%)
- Antibiotics for secondary infection (penicillin, amoxicillin, or metronidazole)
- Discontinuation of smoking and alcohol
- Nutritional support
Surgical Management (Stages II and III)
Surgical management involves resection of necrotic bone to viable, bleeding margins. The goal is removal of all avascular bone — healthy bone bleeds when cut (the “paprika sign” of actively bleeding bone margins indicates adequate resection). For Stage III with extensive involvement, mandibulectomy (segmental resection) followed by microvascular free flap reconstruction (e.g., fibula free flap) is the standard of care.
- Sequestrectomy: Removal of loose, clearly separated necrotic bone sequestra. Appropriate for early Stage I/II disease.
- Marginal resection: Removal of superficial cortical bone to viable margins while preserving mandibular continuity.
- Segmental resection: Complete removal of a section of the mandible when full-thickness necrosis is present. Requires subsequent reconstruction.
- Reconstruction: Fibula free flap is the workhorse for mandibular reconstruction — it provides vascularised bone that can survive in the irradiated bed; can support dental implants in selected cases.
- HBO perioperative protocol: 20 pre-op + 10 post-op HBO dives when surgery is performed in previously irradiated tissue.
Post-Radiation Dental Extractions (Managing Inevitable Extractions)
If a tooth must be extracted after radiation has been delivered to the mandible, the risk of ORN must be minimised:
- Atraumatic extraction technique with minimal mucoperiosteal reflection
- Primary wound closure (sutures) to eliminate exposed bone
- Prophylactic antibiotics (penicillin or amoxicillin) before and after extraction
- HBO perioperative protocol (20 pre-op, 10 post-op) for mandibular teeth in sites that received >60 Gy — the Marx protocol for extractions in irradiated sites
- Avoid local anaesthetic with vasoconstrictors in irradiated tissue where possible — vasoconstrictors further reduce blood flow in already compromised tissue
ORN vs. MRONJ — Comparison
| Feature | ORN (Osteoradionecrosis) | MRONJ (Medication-Related Osteonecrosis) |
|---|---|---|
| Cause | Radiation therapy to head and neck | Antiresorptive drugs: bisphosphonates (zoledronate, alendronate, pamidronate), denosumab; also anti-angiogenic drugs |
| Pathophysiology | Hypoxia, hypovascular, hypocellular (Marx 3H) | Suppressed bone remodelling (osteoclast inhibition) + impaired angiogenesis + infection |
| Definition duration | >8 weeks exposed necrotic bone post-radiation | >8 weeks exposed/fistulated necrotic bone with antiresorptive/anti-angiogenic drug exposure; no radiation to jaw |
| Site preference | Mandible >> maxilla (10:1) | Mandible > maxilla (2:1) |
| Main trigger | Dental extraction in irradiated field | Dental extraction (most common trigger); also spontaneous |
| HBO therapy | Yes — key adjunct (Marx protocol) | Not established as effective; not routinely recommended |
| Patient context | Head and neck cancer history | Osteoporosis (low-dose oral bisphosphonates) or metastatic cancer (IV bisphosphonates — much higher risk) |
Clinical Considerations
- Always obtain a thorough head and neck radiation history before any dental procedure: Before performing extractions, implant placement, periodontal surgery, or other invasive procedures in the head and neck region, ask specifically whether the patient has received radiation therapy to the head and neck — the dose, fields, and when it was completed. This history fundamentally changes the risk profile and management of the procedure. The most catastrophic cases of ORN arise when a post-radiation patient receives a dental extraction without any radiation history awareness or pre-extraction precautions.
- Xerostomia from salivary gland radiation is a major secondary complication: Radiation to the parotid, submandibular, and sublingual glands causes dose-dependent, permanent salivary gland damage — xerostomia (dry mouth). Saliva loss dramatically increases caries risk, periodontal disease, and oral Candida infections. All post-radiation patients must be placed on a lifelong preventive protocol: daily high-fluoride application (1.1% NaF gel in custom trays), regular professional prophylaxis, saliva substitutes, and pilocarpine (muscarinic agonist) to stimulate residual salivary gland function where some acinar cells survive.
- IMRT has reduced but not eliminated ORN risk: Intensity-modulated radiation therapy (IMRT) allows more precise radiation delivery that can spare salivary glands and spare parts of the mandible from the highest doses. As a result, the incidence of ORN has decreased with IMRT compared to older 3D conformal or cobalt techniques. However, ORN still occurs — particularly with tumours that require high-dose radiation close to mandibular bone, and in patients who require post-radiation dental extractions.
- Implants in irradiated bone require careful assessment: Dental implants placed in previously irradiated jaws have higher failure rates and a risk of implant-related ORN. Implant placement in irradiated sites should be considered only when the patient has survived their cancer, the radiation dose to the implant site was not excessive, and HBO prophylaxis (20 pre-op + 10 post-op dives) is used perioperatively. Some centres require a minimum 12-month wait post-radiation before implant placement.
- Exclude tumour recurrence at the site of ORN: ORN and tumour recurrence can present identically — both produce bone exposure, pain, and ulceration in the irradiated jaw. Biopsy of necrotic tissue or adjacent mucosa at the ORN site is mandatory before committing to conservative management. Missing a tumour recurrence because it was assumed to be ORN is a critical diagnostic error with life-threatening implications.
Common Mistakes & Misconceptions
-
Misconception: “ORN and MRONJ are the same condition.”
Correction: ORN and MRONJ are distinct entities with different aetiologies, risk factors, and management approaches — specifically, HBO therapy is a key part of ORN management but is not established as effective for MRONJ. Both produce exposed necrotic jaw bone persisting >8 weeks, but the diagnostic criteria for MRONJ explicitly require no prior radiation to the jaw — if radiation was given, the diagnosis is ORN. A patient on bisphosphonates who also received jaw radiation develops ORN (radiation causation predominates in this scenario, though both pathophysiologies may contribute). -
Misconception: “Maxilla is more frequently affected by ORN than the mandible.”
Correction: The mandible is affected approximately 10 times more frequently than the maxilla. The mandible’s dense cortical bone, limited collateral circulation (end-arterial supply from the inferior alveolar artery), greater tooth-bearing area (with more extraction sites), and its position in the direct path of radiation to floor-of-mouth and tongue tumours all contribute to its disproportionate susceptibility to ORN. -
Misconception: “One week of healing after extraction is sufficient before starting radiation.”
Correction: A minimum of 2 weeks (14 days) healing is required after dental extraction before radiation begins, with 3 weeks being the ideal recommendation. At 1 week post-extraction, the socket is still in the early stages of healing (granulation tissue present, no bone callus) — irradiating this wound disrupts healing and creates a high ORN risk at that site. If the radiation schedule is fixed and cannot be delayed, the dentist and radiation oncologist must communicate directly about timing to optimise healing before RT commencement. -
Misconception: “HBO therapy is only needed for surgical management of ORN.”
Correction: HBO is used in three ORN clinical contexts: (1) primary treatment of Stage I ORN conservatively (20 pre-op + 10 post-op dives with sequestrectomy); (2) perioperative adjunct for surgical ORN management (Stages II and III); and (3) prophylactically around post-radiation dental extractions in high-risk mandibular sites to reduce the risk of ORN developing. The Marx protocol for prophylactic HBO around post-radiation extractions is an important clinical application — 20 dives before the extraction, 10 dives after. -
Misconception: “ORN only occurs within months of radiation completion.”
Correction: ORN can occur at any time after radiation — from weeks to decades post-treatment. The risk does not disappear over time; in fact, the progressive nature of radiation-induced vascular damage means cumulative risk increases lifelong. A patient who received head and neck radiation 20 years ago remains at elevated ORN risk if a tooth is extracted in the irradiated mandible — the same precautions (atraumatic technique, antibiotics, HBO in high-risk sites) apply regardless of the time elapsed since radiation.
Related Topics
References & Sources
- Marx RE, 1983. Osteoradionecrosis: a new concept of its pathophysiology. Journal of Oral and Maxillofacial Surgery, 41(5), 283–288.
- Marx RE, Johnson RP, 1987. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surgery, Oral Medicine, Oral Pathology, 64(4), 379–390.
- Nabil S, Samman N, 2011. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. International Journal of Oral and Maxillofacial Surgery, 40(3), 229–243.
- Lyons AJ, Ghazali N, 2008. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. British Journal of Oral and Maxillofacial Surgery, 46(8), 653–660.
- Teng MS, Futran ND, 2005. Osteoradionecrosis of the mandible. Current Opinion in Otolaryngology and Head and Neck Surgery, 13(4), 217–221.
- Marx RE, Ehler WJ, Tayapongsak P, Pierce LW, 1990. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. American Journal of Surgery, 160(5), 519–524.
- Annane D, Depondt J, Aubert P et al., 2004. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. Journal of Clinical Oncology, 22(24), 4893–4900.
- Chronopoulos A, Zarra T, Ehrenfeld M, Otto S, 2018. Osteoradionecrosis of the jaws: definition, epidemiology, staging and histological findings. A concise review. International Dental Journal, 68(1), 22–30.
Summary
Osteoradionecrosis of the jaw (ORN) is exposed, non-healing necrotic bone in a previously irradiated field that persists for more than 8 weeks, with no evidence of tumour recurrence. It results from radiation-induced hypoxia, hypovascularisation, and hypocellularity (Marx’s 3H hypothesis) that permanently impairs bone healing capacity. The mandible is affected ~10× more frequently than the maxilla. The primary risk factor is total radiation dose >60 Gy; the most common precipitating event is dental extraction within the radiation field. Prevention is the most effective strategy: all teeth of doubtful prognosis must be extracted before radiation, with a minimum 2 weeks (ideally 3 weeks) healing time before RT begins. Management ranges from conservative HBO therapy (20 pre-op + 10 post-op dives) for Stage I ORN to aggressive resection with microvascular reconstruction for Stage III disease. ORN must be distinguished from MRONJ — both present with exposed jaw bone but have different aetiologies and management (HBO is key for ORN but not established for MRONJ).
Key Takeaways
- Definition: Exposed necrotic jaw bone persisting >8 weeks post-radiation, with no tumour recurrence. Mandible >> maxilla (~10:1 ratio). Dose threshold: risk increases significantly above 60 Gy.
- Pathophysiology — Marx’s 3H: Hypoxia + hypovascular + hypocellular irradiated tissue that cannot mount a healing response. Progressive and permanent — risk persists lifelong after radiation.
- Prevention — pre-RT dental clearance: Extract all teeth of doubtful prognosis BEFORE radiation. Minimum 2 weeks (ideally 3 weeks) socket healing before RT begins. Failing to extract before RT and then extracting afterward dramatically increases ORN risk.
- HBO therapy — Marx protocol: 20 pre-operative + 10 post-operative dives at 2.4 ATA, 100% O₂, 90 min per session. Used for Stage I conservative management, surgical ORN (Stages II/III), and prophylactically around post-radiation extractions in high-risk sites.
- ORN vs. MRONJ: Both: exposed bone >8 weeks. ORN = radiation cause; HBO is key treatment. MRONJ = antiresorptive drug cause; HBO not established. Both: mandible > maxilla. A patient who had jaw radiation is ORN — not MRONJ even if on bisphosphonates.

